New cancer drug enters human testing for advanced tumors
Disease control
Terminated
This first-in-human study tested a new cancer drug called PHN-010 in patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check the drug's safety, determine the right dose, and see if it could shrink tumors. The trial incl…
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC